Nasdaq · Biotech stocks database
LFCR (Lifecore Biomedical Inc.) stock: $6.36, $241.1M market cap, $23.0M cash, $380.0M EV, $323.1M fully diluted market cap. Data from Fully Diluted's biotech stocks database.
The Company Lifecore Biomedical, Inc. and its subsidiaries (“Lifecore”, the “Company”, “we” or “us”), located in Chaska, Minnesota, is a fully integrated contract development and manufacturing organization (“CDMO”) that offers highly differentiated clinical and commercial capabilities in the development, cGMP manufacturing and aseptic filling of complex formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials and cartridges, across a wide variety of modalities.
Source: 10-K FY2025 via SEC EDGAR
| Cash | $23.0M |
|---|---|
| Debt | $161.9M |
| Net cash | -$138.9M |
| Enterprise value | $380.0M |
| Basic shares | 37.9M shares |
| Fully diluted shares | 50.8M shares |
| Fully diluted market cap | $323.1M |
| Cash per share | $0.61 |
| Quarterly burn | $2.2M |
| Cash runway | 7.9 quarters |
Cash figures as of 2026-09-30. Database snapshot: 2026-11-07.
Cap table as of 2026-06-30.
Loading LFCR daily closes…